Atypical skin mole may provide means to test for new cancer syndrome

Atypical skin mole may provide means to test for new cancer syndrome

Researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.